GABELLI FUNDS LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$225,000
-3.8%
3,0000.0%0.00%0.0%
Q1 2022$234,000
-13.3%
3,0000.0%0.00%0.0%
Q4 2021$270,000
-2.5%
3,0000.0%0.00%0.0%
Q3 2021$277,000
+18.9%
3,0000.0%0.00%
+100.0%
Q2 2021$233,000
+4.0%
3,0000.0%0.00%
-50.0%
Q1 2021$224,0003,0000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders